Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

AGM Statement

13 May 2025 12:44

RNS Number : 4885I
Chesnara PLC
13 May 2025
 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

13th May 2025

 

CHESNARA plc

("Chesnara" or "the Company")

 

 

RESULT OF THE CHESNARA PLC 2025 ANNUAL GENERAL MEETING

 

 

Chesnara plc (CSN.L) announces that the resolutions put to its Annual General Meeting ("AGM") held on 13th May 2025 were duly passed.

 

The results of the AGM, including the total number of votes received for each resolution, were as follows:

 

 

No.

Resolution

Votes

'for'

%

Votes 'against'

%

Total votes validly cast

Votes 'withheld'

1

To receive and adopt the audited accounts for the year ended 31 December 2024

 

82,910,445

99.98%

18,251

0.02%

82,928,696

154,546

2

To approve the Directors' Remuneration Report for the year ended 31 December 2024

82,141,141

98.97%

856,794

1.03%

82,997,935

49,307

3

To declare a final dividend of 16.08 pence per ordinary share for the year ended 31 December 2024

83,020,792

99.98%

19,770

0.02%

83,040,562

42,680

4

To re-appoint Steve Murray as a director

 

 

82,960,576

99.95%

44,523

0.05%

83,005,099

78,143

5

To re-appoint Carol Hagh as a director

 

 

81,350,807

98.01%

1,654,110

1.99%

83,004,917

78,325

6

To re-appoint Karin Bergstein as a director

 

 

81,828,342

98.58%

1,176,757

1.42%

83,005,099

78,143

7

To re-appoint Luke Savage as a director

 

 

81,830,919

98.59%

1,174,180

1.41%

83,005,099

78,143

8

To re-appoint Eamonn Flanagan as a director

 

82,326,028

99.18%

678,889

0.82%

83,004,917

78,325

9

To re-appoint Tom Howard as a director

 

 

82,956,100

99.94%

48,999

0.06%

83,005,099

78,143

10

To appoint Gail Tucker as a director

 

 

82,971,000

99.96%

37,164

0.04%

83,008,164

75,078

11

To re-appoint Deloitte LLP as auditor

 

 

82,899,949

99.85%

123,681

0.15%

83,023,630

59,612

12

To authorise the directors to determine the auditor's remuneration

 

82,967,342

99.94%

49,496

0.06%

83,016,838

66,404

13

To provide limited authority to make political donations and to incur limited political expenditure

78,444,572

98.38%

1,288,457

1.62%

79,733,029

3,350,213

14

To authorise the directors to allot shares up to a specified amount

 

82,200,304

99.01%

823,363

0.99%

83,023,667

59,575

15

Special resolution - To authorise the directors to disapply pre-emption rights (general corporate purposes)

76,633,840

92.32%

6,372,695

7.68%

83,006,535

76,707

16

Special resolution - To authorise the directors to disapply pre-emption rights (acquisition or other capital investment)

76,504,363

92.17%

6,498,137

7.83%

83,002,500

80,742

17

Special resolution - To give the Company limited authority to purchase its own shares

82,952,359

99.90%

79,329

0.10%

83,031,688

51,554

18

To authorise the directors to allot ordinary shares in relation to an issue of Restricted Tier 1 Instrument up to a specified amount

82,187,738

99.01%

819,754

0.99%

83,007,492

75,750

19

Special resolution - To authorise the directors to disapply pre-emption rights in relation to the issue of Restricted Tier 1 Instruments

82,139,307

98.97%

856,294

1.03%

82,995,601

87,641

20

Special resolution - To authorise the Company to call general meetings on not less than 14 clear days' notice

82,873,003

99.80%

162,435

0.20%

83,035,438

47,804

 

 

The Board is pleased that all resolutions passed with a significant majority.

 

Other Matters

 

The Company's issued share capital on 13th May 2025 consisted of 151,054,162 ordinary shares of 5p each with no shares held in Treasury. Each share carries one voting right and therefore the number of voting rights is 151,054,162.

 

Votes withheld are not a vote in law and have not been counted in the calculation of the votes for and against each resolution or the total votes validly cast.

 

The full text of the resolutions can be found in the Notice of the Annual General Meeting available on the Company's website, www.chesnara.co.uk. In accordance with Listing Rule 9.6.3, full details of the resolutions passed as special business will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

 

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Misha Bayliss - +44 20 7427 5465

Oscar Burnett - +44 20 7427 5435

Teneo

E - chesnara@teneo.com

 

 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers just under one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in the UK, Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 20 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFXLFFEELZBBL
Date   Source Headline
24th Oct 20227:00 amRNSBlock listing Interim Review
19th Oct 20227:00 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAppointment of Group GC & Company Secretary
29th Sep 20227:00 amRNSBlock Listing Application
12th Sep 20227:15 amEQSHardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets
8th Sep 202212:05 pmEQSHardman Talks Video: Interview Chesnara management discuss 2022 half-year results
2nd Sep 20227:00 amRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report
23rd Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSNotice of Interim Results
15th Aug 20222:45 pmEQSHardman & Co: Q&A on Chesnara Plc (CSN) Conservatrix acquisition boosts AuA and cash flow with capacity for more
8th Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20227:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSChesnara Enhances M&A and Commercial Capabilities
29th Jul 20227:15 amEQSHardman & Co Research: Chesnara plc (CSN): Another fine acquisition
22nd Jul 20227:00 amRNSAcquisition
16th Jun 20229:15 amEQSHardman & Co Research: Q&A on Chesnara Plc (CSN): Good performance analysed
31st May 20227:00 amRNSTotal Voting Rights
24th May 20227:00 amEQSHardman & Co Research : Chesnara plc (CSN): Market benefits overwhelm operational challenges
17th May 20221:51 pmRNSResult of AGM
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSAcquisition Completions
22nd Apr 20227:00 amRNSBlock listing Interim Review
21st Apr 20227:00 amRNSNotice of AGM
8th Apr 20227:00 amRNSAcquisition Update
5th Apr 20222:30 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSFinal Results
17th Mar 20227:00 amRNSNotice of Results
15th Mar 20227:00 amRNSTotal Voting Rights
14th Feb 20227:00 amRNSDirectorate Change
2nd Feb 20223:07 pmRNS£200m Inaugural Tier 2 Subordinated Notes Issuance
26th Jan 20227:00 amRNSHolding(s) in Company
17th Jan 20227:00 amRNSDirectorate Change
17th Dec 20217:00 amRNSSenior Leadership Appointment
9th Dec 20217:00 amRNSHolding(s) in Company
2nd Dec 20211:50 pmEQSHardman & Co Research : Chesnara (CSN) Initiation of Coverage: Could be the least worrying dividend you'll get
26th Nov 20211:00 pmRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSAcquisition
22nd Oct 20217:00 amRNSBlock listing Interim Review
19th Oct 20217:00 amRNSDirectorate Change
13th Sep 20217:00 amRNSProposed Acquisition
7th Sep 20217:00 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
12th Aug 20217:00 amRNSNotice of Results
2nd Aug 20217:00 amRNSDirectorate Change
28th May 20214:36 pmRNSHolding(s) in Company
28th May 20217:00 amRNSTotal Voting Rights
21st May 20217:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
18th May 20213:30 pmRNSResult of AGM
12th May 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.